Bausch Health Companies
(NYSE) BHC
Bausch Health Companies Financials at a Glance
Market Cap
$1.90B
Revenue (TTM)
$10.31B
Net Income (TTM)
$155.28M
EPS (TTM)
$0.41
P/E Ratio
12.36
Dividend
$0.00
Beta (Volatility)
1.25 (Average)
Dividend
$0.00
Beta (Volatility)
1.25 (Average)
Price
$5.03
Volume
1,190,614
Open
$5.13
Price
$5.03
Volume
1,190,614
Open
$5.13
Previous Close
$5.02
Daily Range
$4.99 - $5.14
52-Week Range
$4.25 - $8.69
Dividend
$0.00
Beta (Volatility)
1.25 (Average)
Price
$5.03
Volume
1,190,614
Open
$5.13
Previous Close
$5.02
Daily Range
$4.99 - $5.14
52-Week Range
$4.25 - $8.69
BHC News
What Does Bag Holder Mean?
BHC: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Bausch Health Companies
Industry
Pharmaceuticals
Sector
Health CareEmployees
20,300
CEO
Thomas J. Appio
Website
www.bauschhealth.comHeadquarters
Laval, QC H7L 4A8, CA
BHC Financials
Key Financial Metrics (TTM)
Gross Margin
68%
Operating Margin
20%
Net Income Margin
2%
Return on Equity
0%
Return on Capital
9%
Return on Assets
1%
Earnings Yield
8.09%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.90B
Shares Outstanding
370.56M
Volume
1.19M
Short Interest
0.00%
Avg. Volume
2.19M
Financials (TTM)
Gross Profit
$7.04B
Operating Income
$2.07B
EBITDA
$3.10B
Operating Cash Flow
$1.40B
Capital Expenditure
$397.00M
Free Cash Flow
$1.00B
Cash & ST Invst.
$1.32B
Total Debt
$21.21B
Bausch Health Companies Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$2.84B
+10.9%
Gross Profit
$1.79B
-2.3%
Gross Margin
63.02%
N/A
Market Cap
$1.90B
N/A
Market Cap/Employee
$91.66K
N/A
Employees
20,700
N/A
Net Income
$113.72M
-222.3%
EBITDA
$659.38M
-26.8%
Quarterly Fundamentals
Net Cash
$19.88B
+2.7%
Accounts Receivable
$2.35B
+9.7%
Inventory
$1.63B
+1.9%
Long Term Debt
$20.91B
+10.4%
Short Term Debt
$296.46M
-88.9%
Return on Assets
0.59%
N/A
Return on Invested Capital
9.34%
N/A
Free Cash Flow
$402.53M
-18.5%
Operating Cash Flow
$495.92M
-17.5%